【结 构 式】 |
【药物名称】Phortress, 5F-DF-203-L-lysinamide, NSC-710305 【化学名称】N1-[4-(5-Fluorobenzothiazol-2-yl)-2-methylphenyl]-L-lysinamide dihydrochloride 【CA登记号】328087-38-3 【 分 子 式 】C20H25Cl2FN4OS 【 分 子 量 】459.41685 |
【开发单位】University of Nottingham (Originator), Cancer Research UK (Codevelopment) 【药理作用】Breast Cancer Therapy, Chemical Delivery Systems, DRUG DELIVERY, Drug Delivery Systems, Oncolytic Drugs, Solid Tumors Therapy |
合成路线1
Synthesis of intermediate (VII): Conversion of 3-fluoroaniline (I) into 2-amino-5-fluorobenzothiazole (III) can be achieved by first coupling with isocyanate (II) followed by hydrolysis with NaOH, reaction with Br2 and finally heating treatment. Dimerization of substituted benzothiazole (III) by means of refluxing aqueous KOH yields disulfide derivative (IV), which is then condensed with substituted benzoyl chloride (V) in refluxing pyridine to afford derivative (VI). Finally, (VI) is converted into intermediate (VII) by treatment with SnCl2 dihydrate in refluxing HCl/EtOH. Alternatively, intermediate (VII) can be synthesized as follows: substituted aniline (VIII) is first brominated via a Sandmeyer reaction with NaNO2 in HBr and CuBr, and then the nitro group is reduced with SnCl2 in refluxing EtOH to provide derivative (IX). Condensation of (IX) with substituted benzoyl chloride (V) in refluxing pyridine yields amide (X), which is then first treated with Lawesson's reagent and HMPA and then with NaH in NMP to afford benzothiazole derivative (XI). Finally, the nitro group of (XI) is reduced with SnCl2 in refluxing EtOH to yield intermediate (VII). Synthesis of EN 295753: The desired compound can finally be obtained by coupling of intermediate (VII) with Boc-Lys(Boc)-OH (XII) by means of carbodiimide WSC.HCl and HOBt in CH2Cl2, followed by Boc removal with HCl (gas) in CH2Cl2.
【1】 Hutchinson, I.; et al.; Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid produgs. J Med Chem 2002, 45, 3, 744. |
【2】 Chua, M.-S.; Westwell, A.D.; Hutchinson, I.P.; Stevens, M.F.G.; Poole, T.D. (Cancer Research Campaign Technology Ltd.); Substd. 2-arylbenzazole cpds. and their use as antitumour agents. WO 0114354 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 20697 | 3-fluoroaniline; 3-fluorophenylamine | 372-19-0 | C6H6FN | 详情 | 详情 |
(II) | 23530 | benzoyl isothiocyanate | 532-55-8 | C8H5NOS | 详情 | 详情 |
(III) | 47594 | 5-fluoro-1,3-benzothiazol-2-amine; 5-fluoro-1,3-benzothiazol-2-ylamine | C7H5FN2S | 详情 | 详情 | |
(IV) | 47595 | 2-[(2-amino-4-fluorophenyl)disulfanyl]-5-fluoroaniline; 2-[(2-amino-4-fluorophenyl)disulfanyl]-5-fluorophenylamine | C12H10F2N2S2 | 详情 | 详情 | |
(V) | 47596 | 3-methyl-4-nitrobenzoyl chloride | 35675-46-8 | C8H6ClNO3 | 详情 | 详情 |
(VI) | 47597 | N-[5-fluoro-2-([4-fluoro-2-[(3-methyl-4-nitrobenzoyl)amino]phenyl]disulfanyl)phenyl]-3-methyl-4-nitrobenzamide | C28H20F2N4O6S2 | 详情 | 详情 | |
(VII) | 47598 | 1-(5-fluoro-1,3-benzothiazol-2-yl)-3-methyl-1lambda(5)-pyridin-4-amine; 1-(5-fluoro-1,3-benzothiazol-2-yl)-3-methyl-1lambda(5)-pyridin-4-ylamine | C13H12FN3S | 详情 | 详情 | |
(VIII) | 22288 | 4-fluoro-2-nitrophenylamine; 4-fluoro-2-nitroaniline | 364-78-3 | C6H5FN2O2 | 详情 | 详情 |
(IX) | 47599 | 2-bromo-5-fluoroaniline; 2-bromo-5-fluorophenylamine | 1003-99-2 | C6H5BrFN | 详情 | 详情 |
(X) | 47600 | N-(2-bromo-5-fluorophenyl)-3-methyl-4-nitrobenzamide | C14H10BrFN2O3 | 详情 | 详情 | |
(XI) | 47602 | methyl 3-(1-trityl-1H-imidazol-4-yl)propanoate | C26H24N2O2 | 详情 | 详情 | |
(XII) | 37991 | (2S)-2,6-bis[(tert-butoxycarbonyl)amino]hexanoic acid | 2483-46-7 | C16H30N2O6 | 详情 | 详情 |
(XIII) | 47601 | tert-butyl (1S)-5-[(tert-butoxycarbonyl)amino]-1-([[1-(5-fluoro-1,3-benzothiazol-2-yl)-3-methyl-1lambda(5)-pyridin-4-yl]amino]carbonyl)pentylcarbamate | C29H40FN5O5S | 详情 | 详情 |